Shanghai Fosun Pharmaceutical (Group) Co (HK:2196) has released an update.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. conducted its annual general meeting, A Shareholders’ Class Meeting, and H Shareholders’ Class Meeting, where important resolutions were passed including the distribution of final dividends and closure of the register of members for H Shares. A total of 67 shareholders and authorized proxies represented approximately 39.72% of the voting rights at the AGM. Specific directors abstained from voting on certain resolutions due to their vested interests, ensuring transparency and adherence to corporate governance standards.
For further insights into HK:2196 stock, check out TipRanks’ Stock Analysis page.
